The market for weight loss medications is witnessing a significant new entry. A novel oral pill developed by Eli Lilly has recently received approval in the United States, potentially offering a convenient alternative to existing injectable treatments. Key questions arise regarding its overall effectiveness and whether it will succeed in replacing the currently established injection-based solutions.
